Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 340 (3), 189-92

Attenuation of Dopamine Transporter Activity by Alpha-Synuclein


Attenuation of Dopamine Transporter Activity by Alpha-Synuclein

Christophe Wersinger et al. Neurosci Lett.


Alpha-synuclein accumulates in Lewy bodies in idiopathic Parkinson's disease. Neither the normal function nor contribution of alpha-synuclein to the pathophysiology of neurodegeneration is known. Here we show that a normal function of alpha-synuclein is the negative modulation of human dopamine transporter (hDAT) activity. In cotransfected Ltk(-) cells, alpha-synuclein attenuated the reuptake of dopamine by hDAT, in a manner dependent on expression levels of alpha-synuclein. Alpha-synuclein-mediated inhibition of hDAT activity was independent of expression vectors, cell types and methods of transfection. The alpha-synuclein-mediated decrease in DAT activity occurred through diminished uptake velocity of dopamine, without changes in the affinity of hDAT for dopamine. Co-immunoprecipitation studies confirmed the formation of a stable complex between alpha-synuclein and DAT, through direct protein:protein interactions. Thus, under normal (non-toxic) expression conditions, alpha-synuclein negatively modulates dopamine uptake by DAT.

Similar articles

See all similar articles

Cited by 64 PubMed Central articles

See all "Cited by" articles

Publication types

LinkOut - more resources